Physician profile
Christopher M Yardan
NPI 1972866275
$8,138.23
in general payments reported to CMS, 2019-2025
24 companies · $304 in 2025
The $304 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $64.19 · 2021: $2,593 · 2022: $4,154 · 2023: $346 · 2024: $464 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,114.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $4,657.76 | 2019-2025 | Salto Talaris Total Ankle Prosthesis, Cadence, Evos Mini |
| Gramercy Extremity Orthopedics LLC | $2,556.19 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $170.95 | 2021-2024 | Nuzyra |
| Integra Lifesciences Corporation | $120.87 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bioventus LLC | $73.52 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $67.63 | 2024 | Tl-Hex Truelok Hexapod System, Galaxy Fixation System |
| Becton, Dickinson and Company | $47.10 | 2019 | |
| Medline Industries Lp | $42.45 | 2024 | |
| Stryker Corporation | $40.60 | 2024 | Viaflow |
| Treace Medical Concepts, INC. | $39.58 | 2024-2025 | |
| Axogen | $33.06 | 2019-2022 | |
| Nabriva Therapeutics, Plc | $29.49 | 2021-2022 | |
| Organogenesis INC. | $28.58 | 2021-2022 | |
| Nevro Corp. | $28.54 | 2022 | |
| Medtronic, INC. | $28.04 | 2023 | Venaseal |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $26.26 | 2019 | |
| Reprise Biomedical, INC. | $22.34 | 2024 | Miro3d |
| Convatec INC. | $22.00 | 2023 | |
| In2bones USA, LLC | $21.30 | 2021 | |
| Dynasplint Systems INC. | $18.61 | 2024 | Dynasplint |
| Djo, LLC | $18.34 | 2019 | |
| Depuy Synthes Sales INC. | $17.82 | 2024 | Na |
| Avanos Medical | $15.00 | 2019 | |
| Heron Therapeutics, INC. | $12.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$460,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Yardan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.